Clinical Trials Browser

OTHER × omega-N-Methylarginine × Clear all

NCT05660083 2026-02-18

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03236935 2025-03-10

Phase Ib of L-NMMA and Pembrolizumab

Phase 1 Active not recruiting

DermatologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, DNA Repair-Deficiency Disorders

NCT02834403 2023-12-15

L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer Patients

Phase 1/2 Completed

37 enrolled 20 charts

Breast Neoplasms, Triple Negative Breast Neoplasms